(Q45937038)

18 December 2017

review article

1 reference

title

Cardiovascular risk continuum: implications of insulin resistance and diabetes. (English)

1 reference

18 December 2017

1 reference

1 reference

1 reference

W A Hsueh

1

1 reference

18 December 2017

R E Law

series ordinal

2

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

18 December 2017

American Journal of Medicine

published in

1 reference

18 December 2017

volume

105

1 reference

18 December 2017

issue

1A

1 reference

18 December 2017

page(s)

4S-14S

1 reference

18 December 2017

Coronary artery disease in Chinese males without hypercholesterolaemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Relationship between lipoprotein levels and in vivo insulin action in normal young white men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin resistance is not a major determinant of low-density lipoprotein particle size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease ? chicken, egg or neither?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Diabetes and cardiovascular disease. The "common soil" hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin resistance implications for type II diabetes mellitus and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Greater incidence of hospitalized myocardial infarction among Mexican Americans than non-Hispanic whites. The Corpus Christi Heart Project, 1988-1992.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

LDL size and subclass pattern in a biethnic population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Prospective analysis of the insulin-resistance syndrome (syndrome X).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Small LDL, atherogenic dyslipidemia, and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

The intima. Soil for atherosclerosis and restenosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Are we mortgaging the medical profession?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Variations in mortality by weight among 750,000 men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Is insulin really a heart disease risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Does the association of risk factors and atherosclerosis change with age? An analysis of the combined ARIC and CHS cohorts. The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health Study (CHS) investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: stronger associations in lean versus obese subjects. Atherosclerosis Risk in Communities Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin resistance, its consequences, and coronary heart disease. Must we choose one culprit?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Pathobiology of intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Antiplatelet and antithrombotic effects of organic nitrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Atherosclerosis in diabetes: the role of hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Regulation of fibronectin by insulin-like growth factor-I in cultured rat thoracic aortic smooth muscle cells and glomerular mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

The cellular and molecular mechanisms of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Hyperglycemia and microvascular and macrovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. A population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Increased atherosclerosis in streptozotocin-induced diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Effect of external calcium and magnesium on thrombin-induced changes in calcium and magnesium of pig platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Vascular responsiveness and cation exchange in insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Endothelium-dependent vascular relaxation in patients with type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

The pathogenesis of atherosclerosis--an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Regulation of cell motility by mitogen-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Phosphorylation-dependent formation of a quaternary complex at the c-fos SRE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Intracellular targets for antidiabetic sulfonylureas and potassium channel openers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Potassium channels and the coronary circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Metformin Attenuates Agonist-Stimulated Calcium Transients in Vascular Smooth Muscle Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

The biological and pharmacological role of nitric oxide in platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900205-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(98)00205-8

1 reference

18 December 2017

1 reference

18 December 2017